- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour microenvironment and pituitary tumour behaviour
Authors
Keywords
-
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 46, Issue 6, Pages 1047-1063
Publisher
Springer Science and Business Media LLC
Online
2023-04-15
DOI
10.1007/s40618-023-02089-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell sequencing of PIT1-positive pituitary adenoma highlights the pro-tumour microenvironment mediated by IFN-γ-induced tumour-associated fibroblasts remodelling
- (2023) Liang Lyu et al. BRITISH JOURNAL OF CANCER
- The immune microenviroment in somatotropinomas: from biology to personalized and target therapy
- (2023) Sabrina Chiloiro et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs
- (2023) Sabrina Chiloiro et al. JOURNAL OF NEUROENDOCRINOLOGY
- The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications
- (2022) Pedro Marques et al. Pituitary
- Intratumoural spatial distribution of S100B + folliculostellate cells is associated with proliferation and expression of FSH and ERα in gonadotroph tumours
- (2022) Mirela Diana Ilie et al. Acta Neuropathologica Communications
- Understanding the Role of Dopamine in Cancer: Past, Present, and Future
- (2022) Christopher E Grant et al. CARCINOGENESIS
- Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment
- (2022) Simone C. Kleinendorst et al. CLINICAL CANCER RESEARCH
- Multi-Omics Investigations Revealed Underlying Molecular Mechanisms Associated With Tumor Stiffness and Identified Sunitinib as a Potential Therapy for Reducing Stiffness in Pituitary Adenomas
- (2022) Zihao Wang et al. Frontiers in Cell and Developmental Biology
- Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review
- (2022) Mirela Diana Ilie et al. ENDOCRINE-RELATED CANCER
- Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior
- (2022) Dongyun Zhang et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Immunotherapy in pituitary carcinomas and aggressive pituitary tumors
- (2022) Gérald Raverot et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas
- (2022) Mirela-Diana ILIE et al. ENDOCRINE REVIEWS
- Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study
- (2022) Mirela Diana Ilie et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
- (2022) Pia Burman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Macrophage colony‐stimulating factor potentially induces recruitment and maturation of macrophages in recurrent pituitary neuroendocrine tumors
- (2022) Hiroaki Matsuzaki et al. MICROBIOLOGY AND IMMUNOLOGY
- Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression
- (2021) Yu Mei et al. Pituitary
- Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
- (2021) Jing Guo et al. Frontiers in Genetics
- Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors
- (2021) Tae Nakano-Tateno et al. Frontiers in Endocrinology
- Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
- (2021) Ding Nie et al. World Journal of Surgical Oncology
- The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours
- (2021) Pedro Marques et al. JOURNAL OF NEUROENDOCRINOLOGY
- Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
- (2021) Changxi Han et al. Frontiers in Endocrinology
- The Upregulation of Molecules Related to Tumor Immune Escape in Human Pituitary Adenomas
- (2021) Zhiyu Xi et al. Frontiers in Endocrinology
- Targeting Aggressive Pituitary Adenomas at the Molecular Level—A Review
- (2021) Benjamin Voellger et al. Journal of Clinical Medicine
- CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis
- (2020) Hui Yang et al. Molecular Cancer
- Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
- (2020) Valentine Suteau et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes
- (2020) Shinsuke Uraki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In silico analysis of the immunological landscape of pituitary adenomas
- (2020) Jacky T. Yeung et al. JOURNAL OF NEURO-ONCOLOGY
- Targeted systemic and peptide radio-ligand therapy for aggressive pituitary tumors and carcinomas
- (2020) Stephan Petersenn et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- The tumour microenvironment of pituitary neuroendocrine tumours
- (2020) Pedro Marques et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Immune Landscape of Pituitary Neuroendocrine Tumours Reveals Association between Macrophages and Gonadotroph-Tumour Invasion
- (2020) Moitza Principe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness
- (2020) Zihao Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature
- (2020) Camille Duhamel et al. Journal of Personalized Medicine
- Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma: a new emerging treatment?
- (2020) Bastiaan Sol et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas
- (2020) Wenjianlong Zhou et al. JOURNAL OF NEURO-ONCOLOGY
- The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
- (2020) Congxin Dai et al. Frontiers in Endocrinology
- Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study
- (2020) Nazanin Majd et al. Journal for ImmunoTherapy of Cancer
- Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
- (2019) Garima Yagnik et al. Oncotarget
- Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
- (2019) Sayka Barry et al. ONCOGENE
- E-cadherin expression is associated with somatostatin analogue response in acromegaly
- (2019) Eva Venegas-Moreno et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Surgery, octreotide, temozolomide, bevacizumab, radiotherapy and pegvisomant treatment of an AIP mutation positive child
- (2019) Pinaki Dutta et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer and the dopamine D2 receptor: a pharmacological perspective
- (2019) Jillian S Weissenrieder et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors
- (2019) Mizuto Sato et al. Journal of Clinical Medicine
- MANAGEMENT OF ENDOCRINE DISEASE: Immune check point inhibitors-induced hypophysitis
- (2019) Frédérique Albarel et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
- (2019) Marijo Bilusic et al. Journal for ImmunoTherapy of Cancer
- Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab
- (2019) Mario Caccese et al. ANTI-CANCER DRUGS
- Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing's Disease
- (2019) Hanna R Kemeny et al. CLINICAL CANCER RESEARCH
- Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
- (2019) Pedro Marques et al. Acta Neuropathologica Communications
- The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
- (2019) Mirela Diana Ilie et al. Cancers
- Pangenomic Classification of Pituitary Neuroendocrine Tumors
- (2019) Mario Neou et al. CANCER CELL
- Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness
- (2019) Pedro Marques et al. ENDOCRINE-RELATED CANCER
- Definition and diagnosis of aggressive pituitary tumors
- (2019) Leandro Kasuki et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database
- (2019) Julie Garon-Czmil et al. Scientific Reports
- Functions and mechanisms of tumor necrosis factor-α and noncoding RNAs in bone-invasive pituitary adenomas
- (2018) Haibo Zhu et al. CLINICAL CANCER RESEARCH
- The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes
- (2018) Matthew P. Salomon et al. CLINICAL CANCER RESEARCH
- The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy
- (2018) Peng-fei Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab
- (2018) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Imatinib Inhibits GH Secretion From Somatotropinomas
- (2018) Prakamya Gupta et al. Frontiers in Endocrinology
- The Relationship Between Phospho-p38, Matrix Metalloproteinase 9, and Major Histocompatibility Complex Class I Chain-Related Molecule A Expression in Pituitary Adenomas Demonstrates a New Mechanism of Pituitary Adenoma Immune Escape
- (2018) Xinyu Han et al. World Neurosurgery
- The role of the tumour microenvironment in immune therapy
- (2017) Stephan Gasser et al. ENDOCRINE-RELATED CANCER
- Invasive Pituitary Adenoma-Derived Tumor-Associated Fibroblasts Promote Tumor Progression both In Vitro and In Vivo
- (2017) Liang Lv et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model
- (2017) Norbert Chauvet et al. INTERNATIONAL JOURNAL OF CANCER
- Diagnosis and Treatment of Pituitary Adenomas
- (2017) Mark E. Molitch JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Growth Hormone and the Epithelial-to-Mesenchymal Transition
- (2017) Alison L Brittain et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- AIP and the somatostatin system in pituitary tumours
- (2017) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche
- (2017) Fotis Asimakopoulos et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma
- (2017) Q Wang et al. LEUKEMIA
- Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts
- (2017) Balaji Krishnamachary et al. Oncotarget
- Potential Roles of Peripheral Dopamine in Tumor Immunity
- (2017) Xiang Zhang et al. Journal of Cancer
- Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis
- (2016) Omar Abdel-Rahman et al. Future Oncology
- Significance of TNF-α and IL-6 expression in invasive pituitary adenomas
- (2016) J.L. Wu et al. GENETICS AND MOLECULAR RESEARCH
- Alterations of collagen-producing cells in human pituitary adenomas
- (2016) Alimuddin Tofrizal et al. Medical Molecular Morphology
- Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas
- (2016) Hong-Yan Liu et al. MEDICINE
- Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts
- (2016) Siham Moatassim-Billah et al. Oncotarget
- Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
- (2016) Yu Mei et al. Oncotarget
- Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance
- (2015) C. Duluc et al. EMBO Molecular Medicine
- Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas
- (2015) Jian-Qiang Lu et al. ENDOCRINE PATHOLOGY
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas
- (2015) Güliz Demirelli Gültekin et al. JOURNAL OF CLINICAL NEUROSCIENCE
- The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas
- (2015) M Victoria Recouvreux et al. JOURNAL OF ENDOCRINOLOGY
- Relationship between NF-κB, MMP-9, and MICA expression in pituitary adenomas reveals a new mechanism of pituitary adenomas immune escape
- (2015) Zheng Chen et al. NEUROSCIENCE LETTERS
- Pituitary Adenoma and the Chemokine Network: A Systemic View
- (2015) Fabio Grizzi et al. Frontiers in Endocrinology
- Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
- (2015) Kazuyoshi Shiga et al. Cancers
- CSF-1 Receptor Signaling in Myeloid Cells
- (2014) E. R. Stanley et al. Cold Spring Harbor Perspectives in Biology
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again?
- (2013) Lauren E Drake et al. JOURNAL OF PATHOLOGY
- Expression of T-helper-associated cytokines in the serum of pituitary adenoma patients preoperatively and postperatively
- (2013) Lubin Qiu et al. MEDICAL HYPOTHESES
- Gene Expression Profiling Identifies ESRP1 as a Potential Regulator of Epithelial Mesenchymal Transition in Somatotroph Adenomas from a Large Cohort of Patients with Acromegaly
- (2012) Tove Lekva et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cellular and Molecular Specificity of Pituitary Gland Physiology
- (2012) Carolina Perez-Castro et al. PHYSIOLOGICAL REVIEWS
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
- (2011) Paolo Cirri et al. CANCER AND METASTASIS REVIEWS
- Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth
- (2011) M. Moreno-Smith et al. CLINICAL CANCER RESEARCH
- Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin
- (2011) Signe Diness Vindeløv et al. GROWTH HORMONE & IGF RESEARCH
- In Nonfunctional Pituitary Adenomas, Estrogen Receptors and Slug Contribute to Development of Invasiveness
- (2011) Wei Zhou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas
- (2011) Lubin Qiu et al. Pituitary
- The Cyclic Pentapeptide d-Arg3FC131, a CXCR4 Antagonist, Induces Apoptosis of Somatotrope Tumor and Inhibits Tumor Growth in Nude Mice
- (2010) Jeong Mo Kim et al. ENDOCRINOLOGY
- Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer
- (2010) Federica Marchesi et al. JOURNAL OF NEUROIMMUNOLOGY
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- The chemokine system in cancer biology and therapy
- (2009) Alberto Mantovani et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells
- (2009) U. Renner et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Tumor Infiltrating Lymphocytes But Not Serum Pituitary Antibodies Are Associated with Poor Clinical Outcome after Surgery in Patients with Pituitary Adenoma
- (2009) Isabella Lupi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Overexpression of Stromal Cell-Derived Factor 1 and Its Receptor CXCR4 Induces Autocrine/Paracrine Cell Proliferation in Human Pituitary Adenomas
- (2008) F. Barbieri et al. CLINICAL CANCER RESEARCH
- Dopamine Increases the Efficacy of Anticancer Drugs in Breast and Colon Cancer Preclinical Models
- (2008) C. Sarkar et al. CLINICAL CANCER RESEARCH
- Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation
- (2008) Yongho Lee et al. JOURNAL OF ENDOCRINOLOGY
- An Insight to Pituitary Folliculo-Stellate Cells
- (2008) S. Devnath et al. JOURNAL OF NEUROENDOCRINOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
- (2008) Joannes F.M. Jacobs et al. NEURO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now